Literature DB >> 1686814

Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine.

P Glue1, E White, S Wilson, D M Ball, D J Nutt.   

Abstract

The effects of alpha 2-adrenoceptor agonists and antagonists on saccadic eye movements were studied in normal volunteers using the agonist clonidine and the antagonist idazoxan. Changes in blood pressure, heart rate, and several psychological self-ratings were also recorded. Clonidine produced marked slowing of peak saccade velocity, acceleration and deceleration, with deceleration affected more than acceleration, but had no effect on saccade error or latency measurements. In contrast, most saccade parameters were not altered by idazoxan, although fatigue effects were eliminated. Blood pressure, heart rate, and self ratings of alertness were increased by idazoxan and reduced by clonidine, with opposite effects noted on sedation self-ratings. There were no correlations between the clonidine-induced changes in saccade parameters and changes in self-ratings. Although the slowing of some saccade parameters by clonidine may imply that alpha 2-adrenoceptors are involved in control of saccades, it may also be due to sedation. Although alpha 2-adrenoceptor antagonists may abolish fatigue effects, they cannot increase them over baseline values.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686814     DOI: 10.1007/bf02244432

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Merck, Sharp & Dohme Prize for Young Psychopharmacologists: The pharmacology of saccadic eye movements.

Authors:  P Glue
Journal:  J Psychopharmacol       Date:  1991-01       Impact factor: 4.153

2.  Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil.

Authors:  D M Ball; P Glue; S Wilson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The effects of clonidine and yohimbine on human information processing.

Authors:  R Halliday; E Callaway; R Lannon
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

5.  Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication.

Authors:  P Glue; D Nutt; P Glue
Journal:  J Psychopharmacol       Date:  1988-01       Impact factor: 4.153

6.  Efficacy of clonidine in treatment of alcohol withdrawal state.

Authors:  A J Wilkins; W J Jenkins; J A Steiner
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

Authors:  D S Charney; G R Heninger; D E Redmond
Journal:  Life Sci       Date:  1983-07-04       Impact factor: 5.037

8.  Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.

Authors:  M Mattila; T Seppala; M J Mattila
Journal:  Int Clin Psychopharmacol       Date:  1988-07       Impact factor: 1.659

9.  Effect of amphetamine on saccadic and smooth pursuit eye movements.

Authors:  G Tedeschi; P R Bittencourt; A T Smith; A Richens
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Benzodiazepine sensitivity in normal human subjects.

Authors:  D W Hommer; V Matsuo; O Wolkowitz; G Chrousos; D J Greenblatt; H Weingartner; S M Paul
Journal:  Arch Gen Psychiatry       Date:  1986-06
View more
  7 in total

1.  Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil.

Authors:  D M Ball; P Glue; S Wilson; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors.

Authors:  Dipak V Amrutkar; Tino Dyhring; Thomas A Jacobsen; Janus S Larsen; Karin Sandager-Nielsen
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

3.  Pharmacokinetic and behavioral effects of allopregnanolone in healthy women.

Authors:  Erika Timby; Matts Balgård; Sigrid Nyberg; Olav Spigset; Agneta Andersson; Joanna Porankiewicz-Asplund; Robert H Purdy; Di Zhu; Torbjörn Bäckström; Inger Sundström Poromaa
Journal:  Psychopharmacology (Berl)       Date:  2005-09-21       Impact factor: 4.530

4.  Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women.

Authors:  Helena Hedström; Marie Bixo; Sigrid Nyberg; Olav Spigset; Elisabeth Zingmark; Torbjörn Bäckström
Journal:  Psychopharmacology (Berl)       Date:  2008-10-24       Impact factor: 4.530

5.  Fatigue related impairments in oculomotor control are prevented by caffeine.

Authors:  Charlotte J W Connell; Benjamin Thompson; Gustav Kuhn; Michael P Claffey; Shelley Duncan; Nicholas Gant
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

6.  Neurosteroid involvement in threatened preterm labour.

Authors:  Sahruh Turkmen; Torbjörn Bäckström; Yvonne Kangas Flodin; Marie Bixo
Journal:  Endocrinol Diabetes Metab       Date:  2020-12-10

7.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.